Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Critical Care (London, England)|March 28, 2013
Quality of life and pruritus in patients with severe sepsis resuscitated with hydroxyethyl starch long-term follow-up of a randomised trialPiotr Wittbrodt, Nicolai Haase, Dominika Butowska, et al.Australian Critical Care : Official Journal of the Confederation of Australian Critical Care Nurses|August 29, 2024
Nurse-led dysphagia screening in the intensive care unit - An implementation studyAnne Højager Nielsen, Robert Winding, Bettina Hvas Busk, et al.Critical Care Medicine|April 10, 2018
An Open-Loop, Physiologic Model-Based Decision Support System Can Provide Appropriate Ventilator SettingsDan Stieper Karbing, Savino Spadaro, Nilanjan Dey, et al.Ugeskrift for Laeger|March 18, 2021
[Diagnostic approach and evaluation of hospitalized patients with COVID-19]Klaus Nielsen Jeschke, Nanna Reiter, Anne-Mette Hvas, et al.Ugeskrift for Laeger|March 18, 2021
[Clinical management of hospitalised patients with COVID-19]Klaus Nielsen Jeschke, Nanna Reiter, Anne-Mette Hvas, et al.Intensive Care Medicine|October 1, 2016
Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trialPeter B Hjortrup, Nicolai Haase, Helle Bundgaard, et al.Acta Anaesthesiologica Scandinavica|June 24, 2022
Long-term cognitive and functional status in Danish ICU patients with COVID-19Sarah Weihe, Camilla B Mortensen, Nicolai Haase, et al.Acta Anaesthesiologica Scandinavica|September 15, 2020
Characteristics, interventions, and longer term outcomes of COVID-19 ICU patients in Denmark-A nationwide, observational studyNicolai Haase, Ronni Plovsing, Steffen Christensen, et al.The New England Journal of Medicine|June 29, 2012
Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsisAnders Perner, Nicolai Haase, Anne B Guttormsen, et al.Trials|January 29, 2011
Comparing the effect of hydroxyethyl starch 130/0.4 with balanced crystalloid solution on mortality and kidney failure in patients with severe sepsis (6S--Scandinavian Starch for Severe Sepsis/Septic Shock trial): study protocol, design and rationale for a double-blinded, randomised clinical trialAnders Perner, Nicolai Haase, Jørn Wetterslev, et al.Pageof 2